In silico targeting of colony-stimulating factor-1 receptor: delineating immunotherapy in cancer

AIM: Delineate structure-based inhibition of colony-stimulating factor-1 receptor (CSF1R) by small molecule CSF1R inhibitors in clinical development for target identification and potential lead optimization in cancer therapeutics since CSF1R is a novel predictive biomarker for immunotherapy in cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Azhar, Zahra, Grose, Richard P., Raza, Afsheen, Raza, Zohaib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497393/
https://www.ncbi.nlm.nih.gov/pubmed/37711590
http://dx.doi.org/10.37349/etat.2023.00164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497393/
https://www.ncbi.nlm.nih.gov/pubmed/37711590
http://dx.doi.org/10.37349/etat.2023.00164

Ejemplares similares